Therapeutic Effect of Apheresis and Buffy Coat-Derived Platelet Concentrates

被引：0
|
作者：
Zimmermann, Robert [1 ]
机构：
[1] Friedrich Alexander Univ Erlangen Nuremberg, Univ Hosp Erlangen, Dept Transfus Med & Hemostaseol, Erlangen, Germany
来源：
CLINICAL LABORATORY | 2024年 / 70卷 / 08期
关键词：
platelets; platelet function; platelet concentrates; plateletpheresis;
D O I：
10.7754/Clin.Lab.2024.240728
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：1431 / 1433
页数：3
相关论文
共 50 条
  • [31] Hemostatic Efficacy of Pathogen-Inactivated Buffy Coat-Derived Platelet Concentrates in Hemato-Oncological Patients: Outcomes of the Prepares Trial
    Van der Meer, Pieter F.
    Ypma, Paula F.
    van Geloven, Nan
    van Wordragen-Vlaswinkel, Rinie
    van der Bom, Anske
    Kerkhoffs, Jean-Louis
    BLOOD, 2017, 130
  • [32] QUALITY CONTROL OF BUFFY COAT PLATELET CONCENTRATES
    Mijovic, S.
    Draskovic, S.
    Vavic, N.
    Antic, M.
    Mircetic, D.
    Dukic, M.
    VOX SANGUINIS, 2010, 99 : 217 - 218
  • [33] In vitro variables of buffy coat-derived platelet concentrates with residual plasma of down to 10% are stably maintained in new-generation platelet additive solutions
    Gravemann, Ute
    Volgmann, Thorsten
    Min, Kyungyoon
    Philipp, Roman
    Lambrecht, Bernd
    Mueller, Thomas H.
    Seltsam, Axel
    TRANSFUSION, 2015, 55 (07) : 1700 - 1709
  • [34] Fully automated processing of buffy-coat-derived pooled platelet concentrates
    Janetzko, K
    Klüter, H
    van Waeg, G
    Eichler, H
    TRANSFUSION, 2004, 44 (07) : 1052 - 1058
  • [35] PRELIMINARY EVALUATION OF A NOVEL AUTOMATED DEVICE FOR BUFFY -COAT DERIVED PLATELET CONCENTRATES
    Santos, M.
    de la Sota Javier, F.
    Venturini, P.
    Ferreira, F.
    Silva, S.
    Castro, L.
    VOX SANGUINIS, 2010, 99 : 203 - 204
  • [36] Platelet storage lesion of WBG-reduced, pooled, buffy coat-derived platelet concentrates prepared in three in-process filter/storage bag combinations
    Krailadsiri, P
    Seghatchian, J
    Williamson, LM
    TRANSFUSION, 2001, 41 (02) : 243 - 250
  • [37] In Vitro Variables of Buffy Coat-derived Platelet Concentrates with Residual Plasma levels of down to 10% are Stably Maintained in Late-Generation Platelet Additive Solutions
    Gravemann, U.
    Volgmann, T.
    Philipp, R.
    Lambrecht, B.
    Mueller, T. H.
    Seltsam, A.
    TRANSFUSION, 2014, 54 : 96A - 97A
  • [38] Cryopreserved Buffy Coat-Derived Monocytes for Assessment of Erythrophagocytic Response
    Shyian, M. L.
    Cavalcante, L.
    Kipkeu, B. J.
    Acker, J. P.
    Branch, D. R.
    Holovati, J. L.
    TRANSFUSION, 2016, 56 : 141A - 141A
  • [39] In vitro function of buffy coat-derived platelet concentrates stored for 9 days in CompoSol, PASII or 100% plasma in three different storage bags
    Cardigan, R.
    Sutherland, J.
    Garwood, M.
    Bashir, S.
    Turner, C.
    Smith, K.
    Hancock, V.
    Wiltshire, M.
    Pergande, C.
    Williamson, L. M.
    VOX SANGUINIS, 2008, 94 (02) : 103 - 112
  • [40] ADVERSE REACTIONS TO PLATELET TRANSFUSIONS ARE REDUCED BY USE OF PLATELET CONCENTRATES DERIVED FROM BUFFY COAT
    OKSANEN, K
    EBELING, F
    KEKOMAKI, R
    ELONEN, E
    SAHLSTEDT, L
    VOLIN, L
    MYLLYLA, G
    VOX SANGUINIS, 1994, 67 (04) : 356 - 361
12345